Position in SUPN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$2,963,231
+$1,150,077 QoQ
Shares Held
57,327
+57.1% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Derivatives in SUPN
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$733,998
PutShares
14,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JANE STREET GROUP, LLC holds $181,878,118 across 41 Drug Manufacturers - Specialty & Generic names. SUPN ranks #11 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,464,638 | $44,114,896 | |
| 2 | LQDA |
Liquidia Corp
|
795,884 | $30,036,661 | |
| 3 | VTRS |
Viatris Inc
|
2,192,665 | $29,622,903 | |
| 4 | HLN |
Haleon plc
|
2,291,768 | $22,940,596 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
622,607 | $5,927,217 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
240,170 | $4,985,929 | |
| 7 | AQST |
Aquestive Therapeutics, Inc.
|
1,030,050 | $4,274,707 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
725,616 | $4,208,572 |
All Filings in SUPN
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,963,231 | 57,327 | Shares | Defined | 2026-05-12 | |
| 2026-03-31 | $733,998 | 14,200 | Put | Defined | 2026-05-12 | |
| 2025-12-31 | $626,220 | 12,600 | Put | Defined | 2026-02-12 | |
| 2025-12-31 | $1,813,154 | 36,482 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $6,243,618 | 130,647 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $267,624 | 5,600 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $587,501 | 18,639 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,641,144 | 111,180 | Shares | Defined | 2025-05-19 | |
| 2024-09-30 | $1,652,476 | 52,998 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $1,440,380 | 53,846 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $1,634,073 | 47,906 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $576,340 | 19,915 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $1,033,268 | 37,478 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $720,267 | 23,961 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $589,533 | 16,272 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $348,851 | 9,780 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $212,374 | 6,274 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $510,958 | 17,668 | Shares | Defined | 2022-08-16 | |
| 2022-03-31 | $1,725,888 | 53,400 | Put | Defined | 2022-05-17 | |
| 2022-03-31 | $1,127,741 | 34,893 | Shares | Defined | 2022-05-17 | |
| 2021-12-31 | $501,552 | 17,200 | Call | Defined | 2022-02-15 | |
| 2021-12-31 | $1,129,337 | 38,729 | Shares | Defined | 2022-02-15 | |
| 2021-12-31 | $1,717,524 | 58,900 | Put | Defined | 2022-02-15 | |
| 2021-09-30 | $248,031 | 9,300 | Call | Defined | 2021-11-16 | |
| 2021-06-30 | $200,135 | 6,500 | Put | Defined | 2021-08-16 | |
| 2021-06-30 | $354,085 | 11,500 | Call | Defined | 2021-08-16 | |
| 2021-03-31 | $337,773 | 12,902 | Shares | Defined | 2021-05-18 | |
| 2021-03-31 | $458,150 | 17,500 | Call | Defined | 2021-05-18 | |
| 2020-12-31 | $453,684 | 18,032 | Shares | Defined | 2021-02-17 | |
| 2020-12-31 | $236,504 | 9,400 | Put | Defined | 2021-02-17 | |
| 2020-12-31 | $634,032 | 25,200 | Call | Defined | 2021-02-17 | |
| No filing history on record for this holder in this stock. | ||||||